N@N

Matthew DeYoe Downgraded (CC) to Hold and Decreased Target to $44 on, Jun 14th, 2022

Matthew DeYoe of B of A Securities, Downgraded "The Chemours Company" (CC) to Hold and Decreased Target from $48 to $44 on, Jun 14th, 2022.

Matthew has made no other calls on CC in the last 4 months.

There are 4 other peers that have a rating on CC. Out of the 4 peers that are also analyzing CC, 3 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Michael Leithead of "Barclays" Maintained at Hold with Increased Target to $46 on, Monday, May 9th, 2022
• Vincent Andrews of "Morgan Stanley" Maintained at Hold with Increased Target to $41 on, Monday, May 9th, 2022
• Jeffrey Zekauskas of "JP Morgan" Maintained at Hold with Decreased Target to $30 on, Monday, February 14th, 2022

This is the rating of the analyst that currently disagrees with Matthew

---

• Arun Viswanathan of "RBC Capital" Maintained at Buy with Increased Target to $48 on, Wednesday, May 4th, 2022

Contributing Sources

---